Dyne Therapeutics Inc. (DYN)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

25.73

-0.08%

After-hours Dec 13, 2024, 04:39 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07
Revenue	-	-	-	-	-	-	506.00M	1.37B	842.00M	1.47B	3.00M	3.00M	1.58B	2.32B	2.47B	3.55B	3.10B
Cost of Revenue	2.46M	3.35M	1.09M	700.00K	271.00K	24.00K	2.93B	2.28B	2.03B	1.15B	1.15B	268.00M	963.00M	1.18B	1.19B	1.85B	2.01B
Gross Profit	-2.46M	-3.35M	-1.09M	-700.00K	-271.00K	-24.00K	-2.43B	-915.00M	-1.19B	321.00M	-1.14B	-265.00M	622.00M	1.14B	1.27B	1.70B	1.09B
Operating Income	-242.16M	-170.96M	-150.03M	-58.65M	-13.83M	-4.79M	-412.00M	-640.00M	64.00M	-318.00M	-318.00M	714.00M	-236.00M	-11.00M	-834.00M	709.00M	605.00M
Interest Income	7.64M	2.92M	742.00K	56.00K	290.00K	5.00K	-	-	-	-	-	-	-	-	-	-	-
Pretax Income	-235.94M	-168.10M	-149.29M	-59.44M	-14.86M	-4.81M	-538.00M	-1.29B	-427.00M	-268.00M	-417.00M	87.00M	-2.28B	-235.00M	-1.35B	246.00M	267.00M
Net Income	-235.94M	-165.24M	-149.28M	-58.74M	-13.54M	-4.81M	76.00M	-1.24B	50.00M	-67.00M	-356.00M	87.00M	-1.65B	-234.00M	-1.26B	174.00M	264.00M
Selling & General & Admin	31.40M	28.20M	28.72M	13.45M	2.79M	517.00K	189.00M	161.00M	128.00M	-97.00M	97.00M	-22.00M	135.00M	163.00M	-159.00M	-157.00M	-203.00M
Research & Development	210.76M	142.76M	121.31M	45.20M	11.04M	4.28M	-	-	-	-	-	-	-	-	-	-	-
Other Expenses	-	2.86M	-8.00K	-790.00K	-1.32M	-21.00K	-	-	-	-211.00M	-	-59.00M	-	-	-360.00M	-337.00M	-
Operating Expenses	242.16M	170.96M	150.03M	58.65M	13.83M	4.79M	189.00M	161.00M	128.00M	-308.00M	97.00M	-81.00M	135.00M	163.00M	-519.00M	-494.00M	-203.00M
Interest Expense	-	2.92M	-	396.00K	-	5.00K	616.00M	625.00M	546.00M	67.00M	97.00M	-	357.00M	363.00M	415.00M	427.00M	384.00M
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	242.16M	170.96M	150.03M	58.65M	13.83M	4.79M	3.12B	2.44B	2.16B	837.00M	1.24B	187.00M	1.10B	1.34B	675.00M	1.36B	1.81B
Income Tax	-	-2.86M	-8.00K	-700.00K	-1.32M	-11.00K	-610.00M	-45.00M	-474.00M	117.00M	-58.00M	-627.00M	-632.00M	197.00M	315.00M	-75.00M	-151.00M
Shares Outstanding (Basic)	59.68M	51.98M	50.90M	14.40M	45.42M	10.32M	162.00M	129.00M	125.00M	126.00M	100.00M	100.00M	122.00M	120.00M	1.01B	870.00M	1.76B
Shares Outstanding (Diluted)	59.68M	51.98M	50.90M	14.40M	45.42M	10.32M	162.00M	129.00M	126.00M	126.00M	100.00M	100.00M	122.00M	121.00M	1.01B	870.00M	1.76B
EPS (Basic)	-3.95	-3.18	-2.93	-4.08	-0.3	-0.47	0.47	-9.61	0.40	-0.53	-3.56	0.87	-13.48	-1.95	-1.25	0.20	0.15
EPS (Diluted)	-3.95	-3.18	-2.93	-4.08	-0.3	-0.47	0.47	-9.61	0.40	-0.53	-3.56	0.87	-13.48	-1.93	-1.25	0.20	0.15
EBITDA	-233.48M	-164.75M	-148.20M	-58.34M	-14.59M	-4.79M	949.00M	106.00M	736.00M	292.00M	150.00M	113.00M	-1.57B	734.00M	-173.00M	902.00M	830.00M
Depreciation & Amortization	2.46M	3.35M	1.09M	700.00K	271.00K	24.00K	867.00M	766.00M	614.00M	292.00M	467.00M	26.00M	346.00M	408.00M	359.00M	376.00M	333.00M